WeVote
Log In

Bill

Bill

HF 3922

Fair pricing in community pharmacy reimbursement required.

2025-2026 Regular Session Introduced by Bobbie Harder and 4 co-sponsors

Minnesota bill establishing minimum reimbursement standards for community pharmacies to ensure fair pricing and prevent below-cost payments by insurers and pharmacy benefit managers.

Author added Harder
#drugsandmedicine #healthandhealthdepartment
0
WeVote Research Nonpartisan
Bill Summary · HF 3922

Legislative bill overview

HF 3922 requires fair pricing standards for community pharmacy reimbursement in Minnesota, likely addressing how insurance companies and pharmacy benefit managers (PBMs) compensate independent and chain pharmacies. The bill appears designed to prevent reimbursement rates from falling below pharmacies' actual acquisition costs, which has been an industry complaint. This would establish minimum reimbursement thresholds to ensure pharmacy viability.

Why is this important

Community pharmacies have faced financial pressure as reimbursement rates—particularly for generic drugs—have been squeezed by PBMs, leading to pharmacy closures in rural and underserved areas. Fair pricing standards could improve pharmacy access and sustainability, though they may increase costs for insurers and ultimately consumers. This touches a significant healthcare access issue, especially in rural Minnesota.

Potential points of contention

  • Cost implications: Requiring higher reimbursement rates could increase insurance premiums and healthcare costs for employers and individual consumers
  • PBM resistance: Pharmacy benefit managers—powerful middlemen in the supply chain—typically oppose reimbursement floor requirements that reduce their negotiating leverage
  • Definition disputes: What constitutes "fair pricing" and how to calculate actual acquisition costs versus reimbursement rates remains contentious and complex

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.